Browsing Tag
Cancer treatment
82 posts
Norgine expands presence in Germany with new office opening in Wettenberg
Dutch pharmaceutical giant Norgine has inaugurated new offices in Wettenberg, Germany, marking a significant step in its ongoing…
July 21, 2018
Vyriad and Merck launch Phase 1 trial for innovative immuno-oncology drug combination
Vyriad, a US-based biotech company, has partnered with Germany’s Merck to initiate a Phase 1 clinical trial targeting…
July 18, 2018
Eli Lilly strengthens cancer portfolio with acquisition of Armo BioSciences and promising immunotherapy asset
Eli Lilly and Company (Lilly), a global leader in the pharmaceutical industry, has taken a significant step toward…
June 24, 2018
Know how to prevent cancer with naturally available foods
Cancer is one of the deadliest diseases affecting the human and animals, caused due to uncontrolled cell growth…
April 19, 2018
Merck to acquire Australian biotech firm Viralytics for $394m to bolster oncolytic immunotherapy treatments
Significant Acquisition in Pharma Industry: US pharmaceutical giant Merck has announced a definitive agreement to acquire Viralytics, an…
February 22, 2018
Seattle Genetics to acquire Cascadian Therapeutics for $614m to bolster oncology portfolio
Seattle Genetics, a leader in oncology biotechnology, has announced the acquisition of Cascadian Therapeutics for approximately $614 million,…
February 3, 2018
Roche to acquire Ignyta for $1.7bn to enhance oncology portfolio
Roche Pharmaceuticals, a prominent Swiss pharmaceutical company, has entered into a definitive merger agreement to acquire Ignyta, a…
December 22, 2017
Eli Lilly’s Cyramza fails to improve survival in gastric cancer trial despite meeting initial goal
In a recent announcement, Eli Lilly and Company disclosed that its phase 3 RAINFALL trial of the drug…
December 11, 2017
FDA grants accelerated approval to AstraZeneca’s Calquence for mantle cell lymphoma treatment
AstraZeneca has achieved a significant milestone with the early FDA approval of Calquence (acalabrutinib) for the treatment of…
November 1, 2017
India’s CDSCO grants APAC Biotech license for immuno-oncology drug Apceden
The Central Drugs Standard Control Organization (CDSCO), India’s regulatory authority, has granted a commercial license to APAC Biotech…
April 16, 2017